Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
USE OF A NON-PUNGENT CAPSAICIN ANALOGUE TO CONTROL AND TREAT OBESITY AND RELATED COMPLICATIONS
Document Type and Number:
WIPO Patent Application WO/2017/058000
Kind Code:
A3
Abstract:
The present invention relates to N-vanillyloleamide for use in the treatment of overweight and obesity, as well as for any purpose intended to produce an effect on the following aspects: increase of lipolysis, reduction or inhibition of adipogenesis, reduction in weight of the adipose tissue, modification in the size and/or number of adipocytes, increase in satiety and suppression of the appetite.

More Like This:
WO/2023/0615545-HYDROXYMETHYLFURFURAL FOR THE TREATMENT OF MITOCHONDRIAL DYSFUNCTION
JP4684404Anti-inflammatory and pain-relieving topical composition
WO/1998/050044COMPOSITION AND METHOD COMBINING AN ANTIDEPRESSANT WITH AN NMDA RECEPTOR ANTAGONIST, FOR TREATING NEUROPATHIC PAIN
Inventors:
CANALES AGUIRRE ALEJANDRO ARTURO (MX)
MÁRQUEZ AGUIRRE ANA LAURA (MX)
MATEOS DÍAZ JUAN CARLOS (MX)
RODRÍGUEZ GONZÁLEZ JORGE ALBERTO (MX)
MORALES MARTÍNEZ CLAUDIA ELIZABETH (MX)
Application Number:
PCT/MX2016/000097
Publication Date:
August 03, 2017
Filing Date:
September 29, 2016
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
CENTRO DE INVESTIGACIÓN Y ASISTENCIA EN TECNOLOGÍA Y DISEÑO DEL ESTADO DE JALISCO A C (MX)
International Classes:
A61K31/165; A61P3/04
Foreign References:
US4789687A1988-12-06
US6022718A2000-02-08
US20110086031A12011-04-14
JP2009191073A2009-08-27
Other References:
SURI ET AL.: "The emerging role of TRPV 1 in diabetes and obesity", TRENDS IN PHARMACOLOGICAL SCIENCES, vol. 29, no. 1, 12 April 2007 (2007-04-12), HAYWARTH , GB, pages 29 - 36, XP022410627, ISSN: 0165-6147
Attorney, Agent or Firm:
AGUILAR NAVARRO, Carlos Omar et al. (MX)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: REFRIGERATOR

Next Patent: A TYPE OF SMART HOME MANAGEMENT METHOD BASED ON INSTANT MESSASING (IM)